Staff, Author at Green Market Report - Page 2 of 123

StaffJune 10, 2021
15228285-6A99-48E0-B65D-3FE2571CFBFA.png?fit=509%2C312&ssl=1

7min6230

Canna Provisions CEO Meg Sanders is a powerhouse and a connecter of people and talents. She took $5mil+ business and turned it into a thriving and growing $100mil+ company in US cannabis. Canna Provisions’ home base is Lee, MA – a small Berkshires rural town. Next on her deck is finding thoughtful new investors that support the vision of what Canna Provisions has successfully built. Her focus on the future is to embolden the Smash Hits proprietary line of cannabis by Canna Provisions, and supercharge the business and bring it to the next level, while continuing to pay good wages and embolden people’s journey wherever they are in their career or life.”My calling has really been to inspire people to be better people, and as an operator of a $100mill+ vertically integrated cannabis brand in Western Massachusetts, I get to practice that every day with Canna Provisions. I’ve been in the industry over 10 years, previously having been CEO of MindFUL in Colorado (I came from compliance and had never stepped foot in a dispensary before 2010), and have seen pretty much everything there is to see and experience in legal cannabis from seed to sale.”

Full name:

Megan Sanders 

Title:  

CEO

Company:  

Canna Provisions

Years at current company:  

3+

Education profile:  

University of Colorado, Metro State University

 

Most successful professional accomplishment before cannabis:

Before opening Canna Provisions, and before my time as CEO of MindFUL dispensary, I began a youth football club in my hometown of Boulder Colorado. My first year I had 300 kids and 40 coaches and we won two championships. I was basically the proto-female Ted Lasso (call me Theadora Lasso). But also, I started a fly fishing gear company for infants and babies called Anglerbaby when my daughter Taylor was a baby, 1999-2003 or so. My biggest customer was specialty outdoor recreation merchandise retailer Cabela’s, whose catalogue is shipped to all 50 states and to 120 countries. 

Company Mission:

At Canna Provisions our mission is to make life’s journey better by providing premium cannabis products our team gathers in order to present the best of the best to make your supply stop at Canna Provisions a joyous occasion. At each Canna Provisions dispensary in Massachusetts, you will find a great selection of related cannabis products that will “Better your Journey”. We aim to provide and showcase the absolute zenith of customer service and satisfaction within the cannabis space in Massachusetts, carrying only the best partners available in the Commonwealth, while cultivating the best available craft cannabis and exclusive genetics through our proprietary Smash Hits line of Chemdog-grown cannabis.

Company’s most successful achievement:

Besides creating an environment for customer service, education, and community above all else, becoming an award-winning dispensary, being featured in major outlets like the Wall Street Journal and the New York Times, and launching Greg “Chemdog” Krzanowski’s first ever legal cannabis line after changing cultivation and cannabis 30 years ago – all within the first 2 years of business operations – is a track record of success that just keeps expanding.

Has the company raised any capital (yes or no): Yes.

If so, how much?: $5mil equity/$3mil debt which is just about paid off.

Any plans on raising capital in the future?

Yes. We are looking to recapitalize from a small group of thoughtful investors savvy enough to appreciate what we have successfully built in a short time (and through an unprecedented global pandemic) while remaining industry stewards within our communities we operate in through Western Massachusetts.

Most important company 5 year goal:

Besides closing on our third retail dispensary, most important is to fully realize our business plan – which is maximizing our cultivation capacity (at our currently operating Sheffield location, as well as our forthcoming Lee location), and commence manufacturing of both our own products as well as partnering with and launching thoughtful brands who are looking to enter the Massachusetts market with a leading award-winning retail dispensary and cannabis brand.  

Says Meg: “The humans are integral and a priority for us in our company – and a priority for me. And that doesn’t mean this is a place for everyone. It has to be a right fit for the business, even in discussions with our board who are always concerned about payroll. I believe investing in humans is always worth it.”


StaffJune 9, 2021
daily-hit.jpg?fit=700%2C394&ssl=1

8min4270

It’s time for your Daily Hit of cannabis financial news for June 9, 2021.

On the Site

Vireo

Vireo Health International, Inc.  (CSE: VREO; OTCQX: VREOF) announced at this week’s investor day event that it is changing its name to Goodness Growth Holdings, Inc. The company is also changing its ticker symbol to “GDNS” on the Canadian Securities Exchange (CSE: GDNS) and on the OTCQX Market in the United States the ticker symbol will be “GDNSF” (OTCQX: GDNSF).

Jushi

Jushi Holdings Inc.  (CSE: JUSH ) (OTCMKTS: JUSHF ) reported its official financial results for the fourth quarter and the full-year ending December 31, 2020, plus the first-quarter 2021 ending March 31, 2021. Jushi had originally released unaudited results in April. Revenue increased 29.0% sequentially in the first quarter of 2021 to $41.7 million from $32.3 million in the fourth quarter. It missed analyst estimates slightly by $650,000.  Jushi said the increase in revenue was due to solid revenue growth at the BEYOND/HELLO stores in Pennsylvania and Illinois, early revenue contributions from its Virginia retail operations, and increased operating activity at its PAMS and Nevada facilities. The first-quarter net loss was $26.8 million, or $0.18 per diluted share, versus a net loss of $156.7 million, or $1.35 per diluted share, in the fourth quarter This missed analyst estimates by $0.14. Jushi said the $129.9 million improvement in net losses was due to a decrease in fair value losses on derivative liabilities, along with higher revenue and gross profit.

In Other News

Connecticut

According to NRML, House members failed to hold a floor vote on Senate Bill 1118, which sought to legalize the marijuana market in Connecticut, prior to the close of the 2021 regular legislative session. Senate lawmakers had approved the measure on Monday, and Democratic Gov. Ned Lamont called the legislation a “national model for regulating the adult-use cannabis marketplace.” However, Republicans in the House expressed opposition to the bill and successfully delayed lawmakers from casting their votes on the issue prior to Wednesday’s midnight deadline. Nonetheless, several lawmakers have indicated that legislators are likely to revisit and pass a similar version of the legislation if a special session is convened in the coming weeks.

Auxly

Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF)has entered into an agreement with ATB Capital Markets Inc., as sole bookrunner, and Cantor Fitzgerald Canada Corporation, acting as co-lead underwriters of the Offering, together with a syndicate of underwriters, will purchase 47,620,000 Units of the Company, on a bought-deal basis at a price per Unit of $0.315 for gross proceeds of $15,000,300. A.G.P./Alliance Global Partners is acting as the sole U.S. sub-agent and financial advisor to the Company in connection with the Offering in the United States.


StaffJune 8, 2021
daily-hit.jpg?fit=700%2C394&ssl=1

6min6280

It’s time for your Daily Hit of cannabis financial news for June 8, 2021.

On The Site

Top Magazines

It is truly a labor of love to put out a regular print publication. A combination of writers, artists, printers, and distributors. Not to mention the trying to sell the advertising to pay for all of this. While most of us consume our media on our phones, there is something deeply satisfying when reading a story on paper accompanied by beautiful photographs. The pictures on our phones just don’t have the same impact. Plus, who doesn’t love to see themselves or their company featured in a print publication? So with that said, we put together a list of the top cannabis industry print publications. They are listed in alphabetical order.

Tilray

Tilray, Inc. (NASDAQ: TLRY) is launching a new medical marijuana product called Symbios. The company said that the new brand was developed to provide a broader product at a better price point. Potency will range from 15%-18% and all flower is grown in the same Greenhouse as Aphria-branded flower. Current strains include Nordle, Treasure Island, Sour Kush, Jack Herer, Exodus Cheese, and Grower’s Blend (milled flower).

Mydecine

Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) reports that its R&D team has discovered over 40 compounds with pharmacological potential in mushrooms. Mydecine said that it has screened over 25 mushroom species, including various varieties of p. cubensis, and has selected and analyzed over 40 unique compounds found throughout the various species. Of these compounds, a large majority appear to have never been reported before and could be vital to the critical effects of naturally-sourced mushrooms on human health and wellbeing as well as synergistic effects with pure psilocybin.

Brightfield

The cannabis industry’s proof was in 2020’s revenue, but Brightfield’s newest report shows consumer behavior to match exactly what the cannabis industry already knew: people consumed more cannabis during the pandemic than they were before. 

Marley Natural

It is surely a move that Bob Marley never would have dreamed could happen. A dispensary bearing his name, legally selling his beloved herb in his home country of Jamaica. The Marley family and Docklight Brands announced that the Marley Natural will open a new, first-of-its-kind Marley Natural dispensary located at Bob’s former home and recording studio, which is currently the Bob Marley Museum, in Kingston, Jamaica. Privately owned Docklight Brands, Inc. holds the exclusive global rights to Bob Marley cannabinoid products. Docklight was founded by Privateer Holdings.

In Other News

Field Trip Health Ltd. (OTCQX: FTRPF) has applied to list its common shares on the NASDAQ Stock Market. “Psychedelics stand poised to disrupt modern psychiatry, and the NASDAQ is where world class companies whose ambition is disruption list to reach a global audience of investors,” said Ronan Levy , Field Trip’s Executive Chairman. “By applying to list on the NASDAQ, we are declaring to the world that Field Trip is such a world class company.”

HERBL, California’s largest cannabis supply chain solutions company, today announced its acquisition of Blackbird, a premier cannabis distributor and direct-to-consumer software solutions company based in Nevada. The transaction allows HERBL to leverage Blackbird’s ecosystem of national retail and logistics insights to enter the Nevada market and create the most comprehensive supply chain platform in the industry. The acquisition positions HERBL as the leading multi-state supply chain company that serves 98% of California’s and Nevada’s cannabis retailers. BlackbirdGo, Blackbird’s proprietary e-commerce platform, will be seamlessly integrated into HERBL’s retail services offering, providing a new sales channel that connects retailers and consumers to HERBL’s portfolio of best-selling brands. 


StaffJune 8, 2021
THE_DISPENSARY_PRselectsfinal-1-scaled.jpg?fit=1200%2C776&ssl=1

4min14440

It is surely a move that Bob Marley never would have dreamed could happen. A dispensary bearing his name, legally selling his beloved herb in his home country of Jamaica. The Marley family and Docklight Brands announced that the Marley Natural will open a new, first-of-its-kind Marley Natural dispensary located at Bob’s former home and recording studio, which is currently the Bob Marley Museum, in Kingston, Jamaica. Privately owned Docklight Brands, Inc. holds the exclusive global rights to Bob Marley cannabinoid products. Docklight was founded by Privateer Holdings.

“Along with music, herb was such an important part of my father’s life.  He was always a strong advocate for marijuana and all of its healing qualities.  We are thrilled to honor him and his contribution to the world of music and now cannabis at the Bob Marley Museum,” said Stephen Marley.

The company said that the site has already received conditional approval from Jamaica’s Cannabis Licensing Authority. Docklight also said that the opening of the dispensary will allow qualified consumers to enjoy authentic cannabis at Bob’s house.  Jamaican law allows both residents and tourists to use cannabis for therapeutic purposes.  In addition to cannabis, the retail location will sell a full line of Marley accessories and approved CBD products.

“We are thrilled to work with the Marley family to bring the Marley Natural portfolio to Jamaica through this flagship retail location. This unique cannabis experience will bring to life the ethos of Bob Marley,” said Damian Marano, CEO, Docklight Brands. “It is incredibly meaningful to have the first Marley Natural dispensary in the world at the Bob Marley Museum in Kingston, Jamaica.”

One Draw Holdings, a Marley affiliate company, said it plans to open the inaugural Marley Natural retail location at the Bob Marley Museum later in 2021, with future locations planned at Tuff Gong Studio in Kingston and elsewhere on the island.  One Draw will have exclusive rights to operate Marley Natural cannabis retail locations and distribute Marley Natural cannabis products in Jamaica.  This dispensary will be the first in Docklight’s global expansion of the Marley Natural retail footprint, with additional locations planned in North America.


StaffJune 8, 2021
mushroom.jpg?fit=960%2C640&ssl=1

3min4180

Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) reports that its R&D team has discovered over 40 compounds with pharmacological potential in mushrooms. Mydecine said that it has screened over 25 mushroom species, including various varieties of p. cubensis, and has selected and analyzed over 40 unique compounds found throughout the various species. Of these compounds, a large majority appear to have never been reported before and could be vital to the critical effects of naturally-sourced mushrooms on human health and wellbeing as well as synergistic effects with pure psilocybin.

“Most mushrooms, especially the noxious species, have not been investigated for their chemical components,” says Senior Scientist, Duff Sloley. “Most of these compounds are evolved to protect the mushroom’s fruiting body from predation by insects, nematodes, and bacteria and are complex and metabolically expensive to produce. Since these compounds are evolved to affect biological systems and aspects of metabolic pathways, they stand a higher chance of proving to be useful pharmaceuticals,” he continued. “As a consequence, studies of the structural, chemical, and possibly fortuitous pharmacological properties of these unknown compounds may lead to the development of beneficial pharmacological treatments for a number of disease states.”

“We have seen accelerated progress through Mydecine’s fully integrated research and cultivation facilities,” stated Josh Bartch, CEO of Mydecine. “These tremendous advances in our treatment development could not have been possible without our state-of-the-art R&D center and world-class research team. We not only have the ability to discover new compounds, but test them for efficacy, manufacture them for clinical research through a scientific rigor. This end-to-end capability is a critical to successful drug development and sets Mydecine apart.”

The focus on mushrooms is part of the company’s overall strategy to separate itself from its cannabis assets. By doing so, Mydecine can then list its shares on the NASDAQ exchange in the U.S. The company said it had expected to receive the interim order from the Supreme Court of British Columbia on or about June 7, 2021. If shareholders approve, the Spin-Out is anticipated to close on or about the week of July 12, 2021.


StaffJune 7, 2021
daily-hit.jpg?fit=700%2C394&ssl=1

6min4600

It’s time for your Daily Hit of cannabis financial news for June 7, 2021.

On The Site

Planet 13

Planet 13 Holdings Inc. (CSE: PLTH)(OTCQB: PLNHF) reported record sales in May of $11.2 million with gross margins above 50%. The company said that May represents the third consecutive month of record sales as Las Vegas and America return to normal. In a statement, Planet 13 said that hotels across the Las Vegas strip have reported having hotel rooms sold out for the foreseeable future and Planet 13 expects continued strong sales on the back of increased tourist traffic. In May, Planet 13 reported that its first-quarter revenue rose 41% to $23.8 over 2020 before the pandemic had really settled in and lockdowns began. So, there is a great deal of optimism about the second quarter.

Red White & Bloom

Red White & Bloom Brands Inc. (OTC: RWBYF)  closed on a deal raising approximately $36.8 million of new cash and retired $7.7 million of debt. RWB closed on a private placement of 8,445,426 units at a price of C$1.15 per Unit for gross proceeds of C$9,712,239 (or USD $7,769,792). In addition to the statutory 4-month hold, the investors have agreed to a 12-month lock-up of their shares. In addition, RWB completed a private placement to an arm’s length purchaser of a principal amount $6,500,000 unsecured debenture.

Sol Global

Cannabis Law Reports reported that Sol Global (OTC: SOLCF) lost the first round in its lawsuit with investor MMCap. Sol Global had filed a case in the state of New York regarding the repayment of a $50 million loan. At the heart of the lawsuit is a big chunk of Verano shares, which MMCap and the 1235 Fund say belong to them as an option for the repayment of the loan, while Sol Global claims the shares belong to them alone and that all the 1235 Fund gets is a cash repayment. Judge Jennifer Schecter wrote that of all interested parties only one, Verano Blocker 2, specifically agreed to New York as a place of jurisdiction. She also described the group as “sophisticated parties” suggesting all the parties understood what had been agreed to for jurisdiction. MMCap and the 1235 Fund filed their case in Ontario, which Judge Schechter said was consistent with the other clauses in the agreements signed by the parties.

In Other News

Terra Tech Corp. (OTCQX:TRTC) is selling its non-operating N. 4th Street property in Las Vegas, NV. Based on local zoning changes, the property cannot be used for any cannabis-related activities. The sale price of $2.6M results in an approximate $900K balance sheet improvement, after paying off the existing $1.6M mortgage on the property and related sales fees. The sale also eliminates the current monthly burn of carrying the property, including mortgage, taxes, and other associated costs. The closing of the sale is subject to customary conditions and is expected to occur by early August 2021.

GrowGeneration Corp . (NASDAQ: GRWG ) announced that Power Si, a proprietary brand operated and owned by GrowGen, has signed an exclusive distribution agreement with GreenPlanet Wholesale, one of Canada’s oldest and most trusted hydroponic distributors. PowerSi’s original patented formula of mono-silicic acid has consistently proven to improve the yield, strength, and lateral branching of crops and is a must-have for new and experienced growers.  Power Si is widely used in North America and facilitates fast, visible and structured periods of both vegetative and flowering growth.


StaffJune 7, 2021
shutterstock_256424509.jpg?fit=1200%2C800&ssl=1

4min4770

Cannabis companies were getting their houses in order at the start of summer.

Red, White & Bloom

Red White & Bloom Brands Inc. (OTC: RWBYF)  closed on a deal raising approximately $36.8 million of new cash and retired $7.7 million of debt. RWB closed on a private placement of 8,445,426 units at a price of C$1.15 per Unit for gross proceeds of C$9,712,239 (or USD $7,769,792). In addition to the statutory 4-month hold, the investors have agreed to a 12-month lock-up of their shares. In addition, RWB completed a private placement to an arm’s length purchaser of a principal amount $6,500,000 unsecured debenture.

“As evidenced by today’s announcement, we continue to demonstrate our ability to access the needed expansion and working capital, in the least dilutive possible manner to our shareholders, to execute on our strategy. With the previously announced pre-qualification in the State of Michigan and this cash injection, we will now move aggressively towards taking control of our investment in Michigan in which the immediate growth strategy includes rebranding our dispensaries under the High Times banner and preparing for the expansion of cultivation facilities so that we can hit the ground running upon final inspection,” said Brad Rogers, CEO and chairman of RWB, adding: “We also would like to welcome our new strategic investors in Florida. This group of investors have significant design/build capabilities in the State of Florida and will be a welcome addition as we embark on an aggressive expansion in that state.”

On June 4, 2021, RWB’s wholly-owned subsidiary, RWB Florida LLC entered into agreements for an aggregate capital raise of $30,234,224. The raise includes an investment of US $11,337,834 from certain strategic investors directly into RWB Florida. The investors have also advanced an aggregate of $18,896,390 in subordinated debt to RWB Florida at an 8% interest rate due in 36 months.

22nd Century Group

22nd Century Group, Inc. (NYSE American: XXII) entered into a definitive agreement with one institutional investor for the sale of 10 million shares of its common stock at a purchase price of $4.00 per share in a registered direct offering for gross proceeds for $40 million. The offering is expected to close on or about June 9, 2021. “As a result of this important straight common equity financing with one of our long-term institutional investors, 22nd Century will be able to accelerate the Company’s ongoing strategic objectives across all of our plant franchises,” announced James A. Mish, chief executive officer of 22nd Century Group.


StaffJune 3, 2021
patient-2.jpg?fit=960%2C451&ssl=1

3min7760

Empower Clinics Inc. (CSE: CBDT) (OTCQB: EPWCF) is buying Medi + Sure Canada Inc. also called Medisure, a leading Canadian manufacturer of medical devices for patients managing diabetes in a deal valued at $3.5 million. Last year, Empower created a subsidiary company dedicated to the advancement of psilocybin research and patient care, addressing the significant mental health issues of anxiety, depression, post-traumatic stress disorder (PTSD), and addiction.

“This acquisition will provide an immediate impact on our footprint in Canada and bolster our direct-to-consumer testing products initiative while expanding the breadth of our overall service offerings on an accelerated basis. Moreover, consistent with the impact on our two recent acquisitions, the addition of Empower’s financial, marketing, and business development resources is expected to significantly expand the success of Medisure within the first year of operations both on the ground and online,” stated Steven McAuley, Chairman, and CEO of Empower Clinics. “In addition to their great products, MediSure also provides us with an immediate and experienced medical device manufacturing, fulfillment, and distribution point for all forms of testing products in Canada including Kai Care.”

MediSure is a Canadian-owned and operated manufacturer with over a decade of experience meeting the high cost needs of diabetic patients in an affordable and accessible manner. MediSure is a leader in the consumer-driven healthcare sector with a current presence in over 4,000 Canadian pharmacies, 50,000 end-users and unaudited twelve-month trailing revenues of C$1.9 million.

McAuley added “As I’ve stated to our shareholders on multiple occasions throughout 2021, Empower is in the strongest position it has ever been and will continue to grow every aspect of our business unabated and without interruption. In addition to this acquisition, in the last 30 days alone we have announced expansions of our clinics, gone live on our KAI Saliva RT-PCR test with Air Canada and are very advanced on tripling the size of the KAI Medical Laboratory facility. We are hitting on all cylinders and well on our way to becoming a major vertically integrated healthcare company. I fully expect Empower to have continued strong business announcements in June and throughout 2021


StaffJune 3, 2021
shutterstock_1694533150.jpg?fit=667%2C1000&ssl=1

3min10070

Silo Wellness Inc. (CSE: SILO) has signed a letter of intent with Canadian-based mushroom company Mushe Inc. to create the first legal functional and psychedelic mushroom retail outlet based in Jamaica. Silo Wellness currently cultivates psilocybin mushrooms, conducts psychedelic wellness retreats, and is testing a proof-of-concept patent-pending nasal spray.

“As a company, we are very bullish about the high-potential functional mushroom category and the psychedelics sector as a whole. We continue to invest in and expand our operations in Jamaica, the only country where the cultivation, extraction, and sale of psilocybin mushrooms is permissible,” said Douglas K. Gordon, Chief Executive Officer of Silo Wellness. “Consumers are increasingly interested in incorporating mushrooms into their wellness routines. Through our propagation operations, psychedelic wellness retreats, and upcoming retail location, it’s our aim to make mushroom-based products, experiences, and education accessible at a time when so many people are struggling with mental health and other issues.”

According to the company statement, Silo Wellness and Mushe Inc. will build out and operate a “smart shop” retail establishment specializing in the sale of functional and psychoactive mushroom products such as tinctures, capsules, topicals, and edibles, as well as boutique literature and accessories. Earlier this year, Silo Wellness announced a multi-year license agreement with the family of legendary musician Bob Marley for the exclusive worldwide rights to brand, market, and sell a distinct product line of functional and psychedelic mushrooms, which will be sold at the store upon launch.

“In Silo Wellness, we’ve found a partner aligned with our mission to educate consumers about the healing powers of psychedelics and make mushroom-based wellness products and experiences more available,” added Jonathan Rakic, COO of Mushe Inc.  “We look forward to introducing Jamaican residents and tourists to the wide-ranging health and wellness benefits of functional and psychedelic mushrooms – one smart shop at a time.”

While most people associate Jamaica with cannabis and Rastafarians, the country is also considered the epicenter of the psychedelic mushroom movement in the Western Hemisphere, where “magic mushrooms” are openly and legally grown and sold, positioning the island nation to directly benefit from wellness tourism as well as sales of psychedelic mushrooms. The global functional mushroom market size was valued at $46.1 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 9.5% from 2021 to 2028, reports Grand View Research.

 

 


StaffJune 3, 2021
opendor.jpg?fit=960%2C731&ssl=1

6min5140

Kathryn Blackwell is the Co-Founder and CEO of The Open Dør, a national cannabis retail franchise headquartered in Scottsdale, Arizona. With over three decades of experience in the Quick Service Restaurant (QSR) sector, Kathryn has built a successful reputation for elevating brands through effective e-commerce development, product innovation, and strategic communications. Her background in the franchised consumer food industry provided a strong foundation for her transition into the cannabis space. Since establishing The Open Dør in 2020, Kathryn has integrated proven franchise strategies and merchandising practices into the dispensary brand to deliver a modern aesthetic and transform the consumer experience. Prior to entering the cannabis market, Kathryn co-founded international franchisor Kahala Corp, which owned more than 12 brands, among them Cold Stone Creamery, TacoTime, Samurai Sam’s, and others, with more than 3,500 locations operating in 23 countries. 

Full birth name: Kathryn Blackwell

 Title: Co-Founder and CEO

 Company: The Open Dør

 Years at current company: 1

 Education profile: I studied at San Jose State University and was on track to earn a degree in both English and Business Administration with a concentration in both Marketing and Management.  I made the decision to leave school to launch a retail smoothie company which was the precursor to the company that eventually became Kahala Corp, an international franchise organization.

 Most successful professional accomplishment before cannabis: 

I co-founded international franchisor Kahala Corp, which owned more than 12 brands, among them Cold Stone Creamery, TacoTime, Samurai Sam’s, and others, with more than 3,500 locations operating in 23 countries. 

 Company Mission:

“Step in, all are welcome at The Open Dør.”

The Open Dør’s mission is to elevate the cannabis retail experience with a turnkey franchising solution for dispensary operators. The Open Dør’s modern design aesthetic, proven  operational systems, compliance-driven methods, and customer-focused approach, are setting a new standard in dispensary retail. Take the complexity out of cannabis and step into your next venture.

Company’s most successful achievement:

One of the things that The Open Dør is most proud of so far is that we launched this concept and business during the pandemic. Thankfully, because we have a target audience that is in an emerging and thriving market, we are gaining interest quickly with our concept. I’m also proud of our all-star team, which is primarily female professionals. We are also a women-owned business, which is not the norm in the cannabis industry. Overall, we’ve developed an extraordinary retail experience for the consumer and an educational program for The Open Dør staff. This is something that is not currently available in the marketplace and I’m excited to see how we expand our offerings as we continue to grow. 

 Has the company raised any capital (yes or no):

if so, how much?:

Yes, The Open Dør raised enough money to create the dispensary prototype, formalize the business model, and have a successful launch of the new dispensary brand. 

Any plans on raising capital in the future?

Raising capital is strategically valuable for our business in order to support our plans for business growth and implementation. This will directly help various franchise locations across multiple markets. 

Most important company 5-year goal:

The Open Dør’s expansion plans include having multiple locations throughout legalized cannabis states to offer a safe, consistent and educational buying experience for customers, while helping local entrepreneurs navigate the complexities of the cannabis industry. This goal could be bigger if federal legalization comes through before that five year mark. 

 


Don't Miss This Week's Groundbreaking News

Join the thousands of subscribers who stay informed with GMR's exclusive news briefs delivered directly to your inbox every Friday afternoon.

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 2 days

Check your watch – it’s time for your

@GreenMarketRpt – 2 days

Delta 8 Is Getting A Lot Of Attention – Not All Of It Is Good

Back to Top